MicroRNA inhibition using antimiRs in acute human brain tissue sections

Antisense inhibition of microRNAs is an emerging preclinical approach to pharmacoresistant epilepsy. A leading candidate is an "antimiR" targeting microRNA‐134 (ant‐134), but testing to date has used rodent models. Here, we develop an antimiR testing platform in human brain tissue sections...

Descripción completa

Detalles Bibliográficos
Autores principales: Morris, Gareth, Langa, Elena, Fearon, Conor, Conboy, Karen, Lau E‐How, Kelvin, Sanz‐Rodriguez, Amaya, O'Brien, Donncha F., Sweeney, Kieron, Lacey, Austin, Delanty, Norman, Beausang, Alan, Brett, Francesca M., Cryan, Jane B., Cunningham, Mark O., Henshall, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546319/
https://www.ncbi.nlm.nih.gov/pubmed/35656590
http://dx.doi.org/10.1111/epi.17317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546319/
https://www.ncbi.nlm.nih.gov/pubmed/35656590
http://dx.doi.org/10.1111/epi.17317

Ejemplares similares